Integrated care in patients with schizophrenia: Results of trials published between 2011 and 2013 focusing on effectiveness and efficiency

Current Opinion in Psychiatry

Volumn 26, Issue 4, 2013, Pages 384-408

  Schöttle, Daniel ^a   Karow, Anne ^a   Schimmelmann, Benno G ^b   Lambert, Martin ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Assertive Community Treatment; integrated care; randomised controlled trials; schizophrenia; severe mental illness

Indexed keywords

CAREGIVER BURDEN; COST EFFECTIVENESS ANALYSIS; EVIDENCE BASED PRACTICE; FOLLOW UP; HEALTH CARE COST; HOSPITAL PATIENT; HOSPITAL UTILIZATION; HUMAN; MENTAL DISEASE; PATIENT CARE; PATIENT COMPLIANCE; PATIENT SATISFACTION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SCHIZOPHRENIA;

CLINICAL TRIALS AS TOPIC; DELIVERY OF HEALTH CARE, INTEGRATED; EFFICIENCY, ORGANIZATIONAL; HUMANS; SCHIZOPHRENIA;

EID: 84879898469     PISSN: 09517367     EISSN: 14736578     Source Type: Journal    
DOI: 10.1097/YCO.0b013e328361ec3b     Document Type: Review

References (59)

1. Ruggeri M, Leese M, Thornicroft G, et al. Definition and prevalence of severe and persistent mental illness. Br J Psychiatry 2000; 177:149-155.
2. Krabbendam L, Arts B, van Os J, Aleman A. Cognitive functioning in patients with schizophrenia and bipolar disorder: a quantitative review. Schizophr Res 2005; 80:137-149.
3. De Hert M, Cohen D, Bobes J, et al. Physical illness in patients with severe mentaldisorders. II. Barrierstocare, monitoring andtreatmentguidelines, plus recommendations at the system and individual level. World Psychiatry 2011; 10:138-151.
4. Ouzir M, Azorin JM, Adida M, et al. Insight in schizophrenia: from con-ceptualization to neuroscience. Psychiatry Clin Neurosci 201 2; 66:167-1 79.
5. Sideli L, Mule A, La Barbera D, Murray RM. Do child abuse and maltreatment increase risk ofschizophrenia? Psychiatry Investig 2012; 9:87-99.
6. Hor K, Taylor M. Suicide and schizophrenia: a systematic review of rates and riskfactors.J Psychopharmacol 2010; 24 (4 Suppl):81-90.
7. Lambert M, Bock T, Schottle D, et al. Assertive Community Treatment as part of integrated care versus standard care: a 12-month trial in patients with first-and multiple-episode schizophrenia spectrum disorders treated with quetia-pine immediate release (ACCESS trial). J Clin Psychiatry 2010; 71:1313-1323.
8. Kreyenbuhl J, Nossel IR, Dixon LB. Disengagement from mental health treatment among individuals with schizophrenia and strategies for facilitating connectionstocare: a reviewof the literature.Schizophr Bull 2009; 35:696-703.
9. Velligan DI, Weiden PJ, Sajatovic M, et al. Assessment of adherence problems in patients with serious and persistent mental illness: recommen-dations from the Expert Consensus Guidelines. J Psychiatr Pract 2010; 16:34-45.
10. Malone D, Marriott S, Newton-Howes G, et al. Community Mental Health Teams (CMHTs) for people with severe mental illnesses and disordered personality. Schizophr Bull 2009; 35:13-14.
11. Burns T, Catty J, Dash M, et al. Use of intensive case managementto reduce time in hospital in people with severe mental illness: systematic review and meta-regression. BMJ 2007; 335:336.
12. Stein LI, Test MA. Alternative to mental hospital treatment. I. Conceptual model, treatment program, and clinical evaluation. Arch Gen Psychiatry 1980; 37:392-397.
13. Bertelsen M, Jeppesen P, Petersen L, et al. Five-year follow-up of a rando-mized multicentertrial of intensive early intervention vs standard treatmentfor patients with a first episode of psychotic illness: the OPUS trial. Arch Gen Psychiatry 2008; 65:762-771.
14. Marshall M, Lockwood A. Assertive Community Treatment for people with severe mental disorders. Cochrane Database Syst Rev 2000; (2): CD001089.
15. Teague GB, Bond GR, Drake RE. Program fidelity in Assertive Community Treatment: development and use of a measure. Am J Orthopsychiatry 1998; 68:216-232.
16. A.C.T.A. Assertive Community Treatment Association (ACTA). Assertive Community Treatment Association Web Site. http://www.actassociation.org/
17. Burns T, Creed F, Fahy T, et al. Intensive versus standard case management for severe psychotic illness: a randomised trial. UK 700 Group. Lancet 1999; 353:2185-2189.
18. Harrison-Read P, Lucas B, Tyrer P, et al. Heavy users of acute psychiatric beds: randomized controlled trial of enhanced community management in an outer London borough. Psychol Med 2002; 32:403-416.
19. Killaspy H, Bebbington P, Blizard R, et al. The REACT study: randomised evaluation of Assertive Community Treatment in north London. BMJ 2006; 332:815A-818A.
20. Sytema S, Wunderink L, Bloemers W, et al. Assertive Community Treatment in the Netherlands: a randomized controlled trial. Acta Psychiatr Scand 2007; 116:105-112.
21. Essock SM, Mueser KT, Drake RE, et al. Comparison of ACT and standard case management for delivering integrated treatment for co-occurring dis-orders. Psychiatr Serv 2006; 57:185-196.
22. Mc Hugo GJ, Hargreaves W, Drake RE, et al. Methodological issues in Assertive Community Treatment studies. Am J Orthopsychiatry 1998; 68: 246-260.
23. Burns T, Priebe S. Mental healthcare systems and their characteristics: a proposal. Acta Psychiatr Scand 1996; 94:381-385.
24. Killaspy H, Kingett S, Bebbington P, et al. Randomised evaluation of Assertive Community Treatment: 3-year outcomes. Br J Psychiatry 2009; 195:81-82.
25. Harvey C, Killaspy H, Martino S, et al. A comparison of the implementation of Assertive Community Treatment in Melbourne, Australia and London, England. Epidemiol Psychiatr Sci 2011; 20:151-161.
26. van Vugt MD, Kroon H, Delespaul PA, et al. Assertive communitytreatment in the Netherlands: outcome and model fidelity. Can J Psychiatry 2011; 56: 154-160.
27. Kidd SA, George L, Maria O, et al. Recovery-oriented service provision and clinical outcomes in Assertive Community Treatment. Psychiatr Rehab J 2011; 34:194-201.
28. Mc Grew JH, Bond GR, Dietzen L, Salyers M. Measuring the fidelity of implementation of a mental health program model. J Consult Clin Psychol 1994; 62:670-678.
29. Mc Hugo GJ, Draken RE, Teague GB, Xie H. Fidelity to assertive community treatment and client outcomes in the New Hampshire dual disorders study. Psychiatr Serv 1999; 50:818-824.
30. Latimer EA. Economic impacts of assertive community treatment: a review of the literature. Can J Psychiatry 1999; 44:443-454.
31. Gustavsson A, Svensson M, Jacobi F, et al. Cost of disorders of the brain in Europe. Eur Neuropsychopharmacol 2010; 21:718-779.
32. Albert N, Bertelsen M, Thorup A, et al. Predictors of recovery from psychosis analyses of clinical and social factors associated with recovery among patients with first-episode psychosis after 5 years. Schizophr Res 2011; 125:257-266.
33. Bhugra D, Ayonrinde O, Butler G, et al. A randomised controlled trial of assertive outreach vs. treatment as usual for black people with severe mental illness. Epidemiol Psychiatr Sci 2011; 20:83-89.
34. Hansen JP, Ostergaard B, Nordentoft M, Hounsgaard L. Cognitive adaptation training combined with assertive community treatment: a randomised longitudinal trial. Schizophr Res 2012; 135:105-111.
35. Hastrup LH, Kronborg C, Bertelsen M, et al. Cost-effectiveness of early intervention in first-episode psychosis: economic evaluation of a randomised controlled trial (the OPUS study). Br J Psychiatry 2012; 202:35-41.
36. Manuel JI, Covell NH, Jackson CT, Essock SM. Does assertive community treatment increase medication adherence for people with co-occurring psychotic and substance use disorders? J Am Psychiatr Nurses Assoc 2011; 17:51-56.
37. O'Brien S, Mc Farland J, Kealy B, et al. A randomized-controlled trial of intensive case management emphasizing the recovery model among patients with severe and enduring mental illness. Ir J Med Sci 2012; 181:301-308.
38. Sungur M, Soygur H, Guner P, et al. Identifying an optimal treatment for schizophrenia: a 2-year randomized controlled trial comparing integrated care to ahigh-qualityroutinetreatment. Int J Psychiatry Clin Pract 2011;15:118-127.
39. Tempier R, Balbuena L, Garety P, Craig TJ. Does assertive community outreach improve social support? Results from the Lambeth Study of early-episode psychosis. Psychiatr Serv 2012; 63:216-222.
40. Aagaard J, Mueller-Nielsen K. Clinical outcome of Assertive Community Treatment (ACT) in a rural area in Denmark: a case-control study with a 2-year follow-up. Nordic J Psychiatr 2011; 65:299-305.
41. Alonso Suarez M, Bravo-Ortiz MF, Fernandez-Liria A, Gonzalez-Juarez C. Effectiveness of continuity-of-care programs to reduce time in hospital in persons with schizophrenia. Epidemiol Psychiatr Sci 2011; 20:65-72.
42. Barker V, Taylor M, Kader I, et al. Impact of crisis resolution and home treatment services on user experiences and admission to psychiatric hospital. Psychiatrist 2011; 35:106-110.
43. Biong S, Ness O, Karlsson B, et al. Acrisisresolutionand hometreatmentteam in Norway: a longitudinal survey study Part 3. Changes in morbidity and clinical problems from admission to discharge. Int J Ment Health Syst 2012; 6:17.
44. Brugha TS, Taub N, Smith J, et al. Predicting outcome of assertive outreach across England. Soc Psychiatry Psychiatr Epidemiol 2012; 47:313-322.
45. Carpenter J, Luce A, Wooff D. Predictors of outcomes of assertive outreach teams: a 3-year follow-up study in North East England. Soc Psychiatry Psychiatr Epidemiol 2011; 46:463-471.
46. Drukker M, van Os J, Sytema S, et al. Function assertive community treatment (FACT) and psychiatric service use in patients diagnosed with severe mental illness. Epidemiol Psychiatr Sci 2011; 20:273-278.
47. Firn M, Hindhaugh K, Hubbeling D. A dismantling study of assertive outreach services: comparing activity and outcomes following replacement with the FACT model. Soc Psychiatry Psychiatr Epidemiol 2012. [Epub ahead of print].
48. Gold PB, Jones DR, Macias C, et al. A four-year retrospective study of Assertive Community Treatment: change to more frequent, briefer client contact. Bull Menninger Clin 2012; 76:314-328.
49. Huguelet P, Koellner V, Boulguy S, et al. Effects of an assertive community program in patients with severe mental disorders and impact on their families. Psychiatr Clin Neurosci 2012; 66:328-336.
50. Jacobs R, Barrenho E. Impact of crisis resolution and home treatment teams on psychiatric admissions in England. Br J Psychiatry 2011; 199:71-76.
51. Karow A, Reimer J, Konig HH, et al. Cost-effectiveness of 12-month ther-apeutic assertive community treatment as part of integrated care versus standard care in patients with schizophreniatreated with quetiapine immedi-ate release (ACCESS trial). J Clin Psychiatry 2012; 73:e402-e408.
52. Kortrijk HE, Mulder CL, Drukker M, et al. Duration of assertive community treatmentand theinterpretation of routineoutcomedata.Aust N ZJ Psychiatry 2012; 46:240-248.
53. Kortrijk HE, Mulder CL, van der Gaag M, Wiersma D. Symptomatic and functional remission and its associations with quality of life in patients with psychotic disorder in Assertive Community Treatment teams. Compr Psychiatry 2012; 53:1174-1180.
54. Kortrijk HE, Mulder CL, van Vliet D. Changes in motivation for treatment in precontemplating dually diagnosed patients receiving Assertive Community Treatment. Commun Ment Health J 2013. [Epub ahead of print].
55. Hasselberg N, Grawe RW, Johnson S, Ruud T. Treatment and outcomes of crisis resolution teams: a prospective multicentre study. BMC Psychiatry 2011; 11:183.
56. Morrissey JP, Domino ME, Cuddeback GS. Assessing the effectiveness of recovery-oriented ACT in reducing state psychiatric hospital use. Psychiatr Serv 2012; 64:303-311.
57. Drukker M, Joore M, van Os J, et al. The use of a cumulative needs for care monitor for individual treatment v. care as usual for patients diagnosed with severe mental illness, a cost-effectiveness analysis from the healthcare perspective. Epidemiol Psychiatr Sci 2012; 21:381-392.
58. Melau M, Jeppesen P, Thorup A, et al. Theeffectoffiveyearsversustwoyears of specialised assertive intervention for first episode psychosis-OPUS II: study protocol for a randomized controlled trial. Trials 2011; 12:72.
59. Craig TK, Garety P, Power P, et al. The Lambeth Early Onset (LEO) Team: randomised controlled trial of the effectiveness of specialised care for early psychosis. BMJ 2004; 329:1067.